Ajay Kumar Pal

@dpsru.edu.in

Ph.D. Research Scholar at Department of Pharmacology, Delhi Pharmaceutical Sciences and Research University (DPSRU)
Delhi Pharmaceutical Sciences and Research University



                 

https://researchid.co/drajaypal7894

I am a Ph.D. research scholar working on breast cancer in which I am repurposing melatonin receptor agonists for their anticancer activity both in vitro and in-vivo against breast cancer. I have published 8 publications with three research articles, 2 reviewers, and 3 book chapters.

My primary focus is the inhibit the Pan-oncogenes regulating EMT and angiogenesis pathways in breast cancer cells and tumor microenvironment.

EDUCATION

• Pursuing Ph.D. in Pharmacy from Delhi Pharmaceutical Sciences and Research University (DPSRU), New Delhi with a specialization in Pharmacology and Cancer research since January 2019.
• Post Graduated in Pharmacy (Master of Pharmacy) in 2017 from Babasaheb Bhimrao Ambedkar University, Lucknow with a CGPA of 7.38.
• Graduated in Pharmacy (Bachelor of Pharmacy) in 2015 from K.I.E.T School of Pharmacy, affiliated to Dr. A.P.J. Abdul Kalam Technical University (. U), Lucknow with an aggregate of 71.89%.
• Qualified Intermediate (10+2) from Central Board of Secondary Education (C.B.S.E), New Delhi in 2011 with aggregate 68%.
• Qualified High School (10) from Central Board of Secondary Education (C.B.S.E) in (2009) with an aggregate of 78.20%.

RESEARCH, TEACHING, or OTHER INTERESTS

Pharmacology (medical), Oncology, Cancer Research, Molecular Biology

FUTURE PROJECTS

Epithelial-Mesenchymal Pathway


Applications Invited
45

Scholar Citations

4

Scholar h-index

2

Scholar i10-index

RECENT SCHOLAR PUBLICATIONS

  • Role of Angiogenesis and Its Biomarkers in Development of Targeted Tumor Therapies
    A Pathak, AK Pal, S Roy, M Nandave, K Jain
    Stem Cells International 2024 2024

  • Metabolomics and EMT markers of breast cancer: a crosstalk and future perspective
    AK Pal, P Sharma, A Zia, D Siwan, D Nandave, M Nandave, RK Gautam
    Pathophysiology 29 (2), 200-222 2022

  • Functional nanomaterials and nanocomposite in cancer vaccines
    N Raina, AK Pal, R Rani, A Sharma, M Gupta
    Nanotherapeutics in Cancer Vaccination and Challenges, 241-258 2022

  • Effect of parthenolide, an NLRP3 inflammasome inhibitor, on insulin resistance in high-fat diet-obese mice
    PK Chinta, S Tambe, D Umrani, AK Pal, M Nandave
    Canadian Journal of Physiology and Pharmacology 100 (3), 272-281 2022

  • Punica granatum (Pomegranate): An Insight into the Prevention and Treatment of Cancer
    NM Pal AK, Gautam RK
    PUNICA GRANATUM CULTIVATION, PROPERTIES AND HEALTH BENEFITS 2021

  • Advances in delivery of nanomedicines and theranostics for targeting breast cancer
    AK Pal, M Nandave, RK Gautam
    Advanced Drug Delivery Systems in the Management of Cancer, 387-407 2021

  • Chemoprophylactic activity of nitazoxanide in experimental model of mammary gland carcinoma in rats
    AK Pal, M Nandave, G Kaithwas
    3 Biotech 10, 1-12 2020

  • Butea monosperma flower extract partially reduces high-fat diet induced obesity in experimental rats
    G Golandaz, AK Pal, V Uplanchiwar, RK Gautam
    Obesity Medicine 17 (100179) 2020

MOST CITED SCHOLAR PUBLICATIONS

  • Metabolomics and EMT markers of breast cancer: a crosstalk and future perspective
    AK Pal, P Sharma, A Zia, D Siwan, D Nandave, M Nandave, RK Gautam
    Pathophysiology 29 (2), 200-222 2022
    Citations: 17

  • Butea monosperma flower extract partially reduces high-fat diet induced obesity in experimental rats
    G Golandaz, AK Pal, V Uplanchiwar, RK Gautam
    Obesity Medicine 17 (100179) 2020
    Citations: 10

  • Effect of parthenolide, an NLRP3 inflammasome inhibitor, on insulin resistance in high-fat diet-obese mice
    PK Chinta, S Tambe, D Umrani, AK Pal, M Nandave
    Canadian Journal of Physiology and Pharmacology 100 (3), 272-281 2022
    Citations: 9

  • Chemoprophylactic activity of nitazoxanide in experimental model of mammary gland carcinoma in rats
    AK Pal, M Nandave, G Kaithwas
    3 Biotech 10, 1-12 2020
    Citations: 7

  • Functional nanomaterials and nanocomposite in cancer vaccines
    N Raina, AK Pal, R Rani, A Sharma, M Gupta
    Nanotherapeutics in Cancer Vaccination and Challenges, 241-258 2022
    Citations: 1

  • Advances in delivery of nanomedicines and theranostics for targeting breast cancer
    AK Pal, M Nandave, RK Gautam
    Advanced Drug Delivery Systems in the Management of Cancer, 387-407 2021
    Citations: 1

Industry, Institute, or Organisation Collaboration

1. B.S. Anangpuria Institute of Pharmacy, Ballabhgarh, Haryana, INDIA
2. Babasaheb Bhimrao Ambedkar University (BBAU), Luckow, Uttar Pradesh, INDIA
3. Delhi Pharmaceutical Science and Research University
4. Gurugram University, Haryana
5. National Institute of Pharmaceutical Education and Research (NIPER)- Raibareli, INDIA
6. Maharishi Mankandeshwar University, Ambala, Haryana, INDIA

INDUSTRY EXPERIENCE

Innodata. Inc